Eisai is committed to supporting patient access by helping with your reimbursement questions. With this in mind, the ALOXI® (palonosetron HCI injection) Reimbursement site has been designed to provide healthcare professionals with information related to the insurance reimbursement environment for ALOXI®.
Indication in Adults
ALOXI® (palonosetron HCl) injection is used in adults to help prevent nausea and vomiting on the day of chemotherapy that is highly likely to cause nausea and vomiting, and up to 5 days following chemotherapy that is moderately likely to cause nausea and vomiting.
Indication in Pediatrics
ALOXI® (palonosetron HCl) injection is used in children 1 month old to less than 17 years of age to help prevent nausea and vomiting on the day of chemotherapy that is moderately or highly likely to cause nausea and vomiting.
Important Safety Information:
- ALOXI® can cause allergic reactions that can be serious. Tell your doctor or nurse right away if you have any of these following symptoms of a serious allergic reaction: hives, swelling of the face, trouble breathing and chest pain
- The most common side effects of ALOXI® in adults are headache and constipation
- Tell your doctor or nurse if you are taking other medications or if you are pregnant or breastfeeding or plan to become pregnant or breastfeed
For more information about ALOXI®, talk to your doctor or see full Prescribing Information.
ALOXI® is available by prescription only.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit http://www.FDA.gov/medwatch or call 1-800-FDA-1088.